- Home
- CBLL vs RLAY Comparison
CBLL vs RLAY Comparison
Compare CBLL & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBLL
- RLAY
- Stock Information
- Founded
- CBLL 2014
- RLAY 2015
- Country
- CBLL United States
- RLAY United States
- Employees
- CBLL N/A
- RLAY N/A
- Industry
- CBLL
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CBLL
- RLAY Health Care
- Exchange
- CBLL Nasdaq
- RLAY Nasdaq
- Market Cap
- CBLL 710.2M
- RLAY 576.1M
- IPO Year
- CBLL 2024
- RLAY 2020
- Fundamental
- Price
- CBLL $16.35
- RLAY $3.60
- Analyst Decision
- CBLL Strong Buy
- RLAY Strong Buy
- Analyst Count
- CBLL 6
- RLAY 11
- Target Price
- CBLL $33.00
- RLAY $18.40
- AVG Volume (30 Days)
- CBLL 380.8K
- RLAY 1.6M
- Earning Date
- CBLL 08-14-2025
- RLAY 08-05-2025
- Dividend Yield
- CBLL N/A
- RLAY N/A
- EPS Growth
- CBLL N/A
- RLAY N/A
- EPS
- CBLL N/A
- RLAY N/A
- Revenue
- CBLL $71,535,000.00
- RLAY $7,679,000.00
- Revenue This Year
- CBLL $33.98
- RLAY $17.59
- Revenue Next Year
- CBLL $28.82
- RLAY N/A
- P/E Ratio
- CBLL N/A
- RLAY N/A
- Revenue Growth
- CBLL 44.86
- RLAY N/A
- 52 Week Low
- CBLL $10.01
- RLAY $1.78
- 52 Week High
- CBLL $32.75
- RLAY $10.72
- Technical
- Relative Strength Index (RSI)
- CBLL N/A
- RLAY 57.25
- Support Level
- CBLL N/A
- RLAY $3.50
- Resistance Level
- CBLL N/A
- RLAY $3.86
- Average True Range (ATR)
- CBLL 0.00
- RLAY 0.18
- MACD
- CBLL 0.00
- RLAY 0.02
- Stochastic Oscillator
- CBLL 0.00
- RLAY 65.79
About CBLL CeriBell Inc. Common Stock
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).